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Acquisition of resistance to third-generation cephalosporins in NTS species has been reported from various parts of the world. [5, 6] The mechanism of resistance to ceftriaxone has been identified to be plasmid-mediated extended-spectrum β-lactamases (ESBLs) and/or AmpC (pAmpC) β-lactamases. [7, 8] These antimicrobial resistance (AMR) determinants are disseminated to other Salmonella spp. through mobile genetic elements. [9] There are infrequent reports of ceftriaxone resistance in NTS have been documented from India. [10] [11] [12] Furthermore, different types of ESBL gene such as bla TEM , bla SHV , bla OXA and bla CTX-M have been reported in ceftriaxone-resistant (CR)-NTS. [7, 8] The purpose of this study was to study the incidence and molecular profiling of ceftriaxone resistance in NTS causing bacteraemia and diarrhoeal illness. We aim to characterise CR-NTS isolates for the presence of AMR determinants targeting the various β-lactamases genes. The present study also characterises the plasmid replicon profiles-containing β-lactamase genes in NTS to elucidate the molecular mechanism of transferable plasmid-mediated AMR.
MaterialS and MethOdS

Bacterial isolates
Retrospectively, CR-NTS strains from blood, stool and exudates were isolated from January 2010 to December 2018 at the Christian Medical College, Vellore, Tamil Nadu, India. Serogroup identification of NTS isolates was performed as a part of routine diagnostics using standard biochemical tests and slide agglutination test.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using the disc-diffusion method with six antimicrobial agents, including ampicillin (10 µg), chloramphenicol (30 µg), trimethoprim/sulphamethoxazole (1.25/23.75 µg), nalidixic acid (30 µg), ciprofloxacin (5 µg) and ceftriaxone (30 µg). Minimum inhibitory concentration (MIC) for ceftriaxone was further determined by the E-test strip (Biomeurix, France) and by broth microdilution (BMD) method in accordance to the Clinical and Laboratory Standards Institute (CLSI) 2010 guidelines and interpretative criteria (Wayne, 2010) . Escherichia coli ATCC 25922, Enterococcus faecium ATCC 29212 and Pseudomonas aeruginosa ATCC 27853 were used as quality control strain for antimicrobial susceptibility testing. [13] 
Molecular detection of antimicrobial resistance gene Genomic DNA extraction
Total genomic DNA of CR-NTS strains was extracted from colonies grown overnight (14-16 h) at 37°C on blood agar (in-house) using the QIAamp DNA Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturers' instructions. Total DNA was extracted and stored at −20°C until further use.
Detection of β-lactamases by multiplex polymerase chain reaction
Total DNA of all CR-NTS strains were subjected to multiplex polymerase chain reaction (PCR) for the detection of various β-lactamase genes as described earlier using the Multiplex PCR kit (Qiagen, Valencia, CA, USA). This includes genes such as AmpCs (bla MOX , bla CMY , bla DHA , bla FOX , bla ACC and bla ACT ) [14] and ESBLs (bla SHV , bla TEM , bla VEB , bla PER , bla CTXM-1 like, bla CTXM-2 like , bla CTXM-8 like , bla CTXM-9 like and bla CTXM-25 like ). [15, 16] PCR was carried out with the Veriti Thermal Cycler (Applied Biosystems, Foster City, CA, USA). Amplicons were visualised in a 2% agarose gel containing ethidium bromide. Known positive controls for each of the aforementioned resistant genes have been tested in every run, and amplicons sizes were compared with the 100 bp DNA ladder (Taoyuan, Taiwan).
Plasmid replicon typing
Plasmid incompatibility (Inc) groups typing was performed for the study isolates. ESBL gene-positive isolates were screened for IncHI2 plasmid and IncI1 for AmpC gene-positive isolates, as described previously. [17] reSultS During the study period, 826 NTS isolates were identified. Among which, 5% (n = 42) were resistant to ceftriaxone. Majority of CR-NTS isolates (71%; 30/42) were Salmonella Group B, followed by 7% (n = 3), 12% (n = 5) and 9.5% (n = 4) of Salmonella Group E, Salmonella group C1/C2 and other Salmonella spp., respectively. Most of the CR-NTS isolates were from faeces (n = 26). A subset of 33 CR-NTS was characterised in this study. The isolate details are given in Table 1 .
Antimicrobial susceptibility profile of ceftriaxone susceptible (CS) NTS versus CR NTS showed significant variations. For CS-NTS, >85% susceptibility for ampicillin, chloramphenicol, co-trimoxazole and ciprofloxacin was noted. In contrast, high rates of resistance were noted for CR-NTS with 100% and 93% resistant to ampicillin and nalidixic acid, respectively (data not shown). Notably, 48% (n = 16/33) of the CR-NTS shown multidrug-resistant phenotype with the profile of resistant to ampicillin, chloramphenicol and co-trimoxazole. Ceftriaxone MIC by E-test shows a value of >32 µg/ml for all the studied isolates, whereas MIC by BMD ranges from 32 to 1024 µg/ml. Molecular screening of β-lactamases shown that all the CR-NTS isolates harboured either bla CTX-M-1 like or bla CMY gene. Among these, 54% (n = 18) and 48% (n = 16) of the isolates harboured bla CTX-M-1 like and bla CMY gene, respectively. Notably, 78% (n = 14) of the bla CTX-M-1 like positives also co-harboured bla TEM gene (Dual ESBLs). While, 19% (n = 3) of the bla CMY positives co-harboured bla TEM gene (Amp + ESBL). Interestingly, two isolates were found to have combination of genes that include bla CTX-M-1 like + bla TEM + bla CMY and bla SHV + bla TEM + bla CMY . Three isolates carried bla CMY and bla TEM genes. MIC's associated with the β-lactamases found to vary significantly. High-level resistance of MIC being 1024 µg/mL was noticed for CR-NTS harbouring bla CTX-M-1 . Conversely, bla CMY -positive isolates showed MIC ranging from 32 to 256 µg/mL, which is comparatively four-fold lesser than bla CTX-M-1 producers. This characteristically explains high-level resistance to ceftriaxone mediated by ESBLs (bla CTX-M-1 ) than AmpC (bla CMY ) β-lactamases. On plasmid analysis, IncH12 and IncI1 plasmids were identified in 2 and 11 isolates, respectively. Further, details of antimicrobial susceptibility profile, MIC value and resistance gene profile of the study isolates are provided in Table 1 .
diScuSSiOn
The incidence of CR-NTS is steadily increasing in India. In this study, most of the CR-NTS isolates were of Salmonella Group B. In majority of the earlier reports, Salmonella Group B was prevalent among NTS with high variability in the antimicrobial susceptibility profile. Studies on NTS from Ethiopia and China have reported a very low susceptibility of <15% to different antimicrobials. Whereas, other studies on NTS have reported >50% susceptibility to antimicrobial agents. [18, 19] Furthermore, CLSI guidelines do not recommend reporting of antimicrobial susceptibility testing for NTS. This varying susceptibility profile necessitates the continuous monitoring of antibiotic susceptibility of this pathogen to track the emerging resistance trends.
CR-NTS isolates have been reported worldwide, including Europe, Asia and the United States. [8, [20] [21] [22] [23] [24] Further, there is a report of CR Salmonella serotypes discovered in the pilgrims of Hajj. [25, 26] These travellers act as a carrier and then spread across the different regions of the world. This implies that global transportation might play an important role in the spread of resistance when people travel to a region with a high prevalence of AMR. [26] The most common resistance mechanism involved in the ceftriaxone resistance is the production of plasmid-mediated AmpC β-lactamases, particularly bla CMY-2 variant; different ESBLs such as bla CTX-M . [27] bla CTX-M (18/33; 54%) and bla CMY (16/33; 48%) were the most commonly encountered β-lactamases in this study. This finding concurs with the previous reports of the high prevalence of bla CMY and bla TEM-1 among CR-NTS in India. [8] Co-occurrence of plasmid-mediated AmpC and ESBL was encountered in 5/33 (15%) isolates. Although resistance gene variants has to be identified by sequencing to confirm the ESBL phenotype, it is considered to be one of the limitations of this study. Studies also indicate that the co-occurrence of these genes may pose problems during treatment, as these enzymes can hydrolyse including carbapenems if there is an additional porin mutation. A similar phenomenon was previously reported in Klebsiella spp. [28] Strikingly, CR-NTS isolates from faeces specimens showed a significant dominance of bla CTX-M-1 like gene until 2014, followed by the emergence of bla CMY from 2015 onwards, except one isolate in early 2016 producing bla CTX-M-1 like (NTS-22). However, between the year 2015 and early 2016, an unknown event has occurred which triggered the changes in the resistance determinants from bla CTX-M-1 like to bla CMY contributing for the resistance in CR-NTS. Although this finding was evident, the molecular mechanism contributed for this swift is yet to be explored.
Plasmids are known to play an important role in gaining AMR and implicated in the propagation of AMR determinants. The high prevalence of IncHI2 plasmids in Salmonella group B associated with bla CTX-M , particularly in Salmonella typhimurium was observed in the earlier report from China. [19] Other plasmids such as IncI1, IncA/C, IncFII, IcK and IncN are reported to carry bla CTX-M and bla CMY genes. Similarly, IncH12 and IncI1 plasmids were identified in the isolates that are positive for bla CTX-M and bla CMY in this study. However, the inability to associate an Inc group just with the presence of resistance determinants is another limitation of the present study, since the plasmid typing was not performed in the transconjugants with the respective plasmid of interest to demonstrate the definite role of plasmid in AMR dissemination.
cOncluSiOn
This study reports the prevalence of 5% CR-NTS. In this study, ceftriaxone resistance was commonly seen in Salmonella serogroup B, and the resistance mechanism was found to be due to the presence of plasmid-mediated resistance genes such as bla CTX-M-1 like, bla TEM and bla CMY. In addition, our data also show that both IncH12 and IncI1 plasmids involved in CR-NTS. The presence of these genes in plasmid further poses a serious threat due to its risk of potential dissemination. The increase in CR results in patients relying on azithromycin, the promising alternative to ciprofloxacin and ceftriaxone. While, resistance to azithromycin has also begun to emerge in Salmonella. Therefore, there is an urgent need to control the spread of drug-resistant Salmonella and overuse of antimicrobial agents to improve the treatment strategy for salmonellosis.
